This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
Clinical trial NCT03165240 · COMPLETED
Trial details
- NCT number
- NCT03165240
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2020-04-16
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.